Pharmaceutical Analysis & Statistics in Europe Countries, November 2014

You might be interested in: Therapeutics, Drug, Cancer, more »

1-30 of 39 reports

Purchase Reports From Reputable Market Research Publishers

Key Pharma News 17 NOVEMBER 2014

Key Pharma News 17 NOVEMBER 2014

  • $ 1 415
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Conference Reveals Future Diversification Of HCV Market Industry Brief - Intarcia/Servier Sign Ex-US Partnership For ITCA 650 In Diabetes Industry Brief - Genmab Transfers Ofatumuma ...

  • Industries : Pathology
  • Countries : Luxembourg, Germany, Belgium
Key Pharma News 20 OCTOBER 2014

Key Pharma News 20 OCTOBER 2014

  • $ 1 415
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Shire/AbbVie Combination Now Unlikely Industry Trend Analysis - J&J Bolsters Immunotherapy Pipeline With Second Aduro Collaboration Industry Brief - Eisai Names Partner For Pan ...

  • Industries : Drug and Medication
  • Countries : United States, India, World, United Kingdom
CNS Drug News 17 NOVEMBER 2014

CNS Drug News 17 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - FDA Approval Will See Lemtrada Become A Blockbuster Industry Brief - Impax Submits MAA For IPX066 Industry Brief - NeuroDerm Reports Positive Top-Line Phase II Results In Mod ...

  • Industries : Drug and Medication
  • Countries : Australia, Luxembourg, United States, Russian Federation, Germany, Belgium
Drug Delivery Insight 17 NOVEMBER 2014

Drug Delivery Insight 17 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Catalent Increases Service Offerings With Another Acquisition Industry Trend Analysis - BMS Interest Underlines Vitality Of Underserved IPF Market Industry Trend Analysis - AstraZeneca ...

  • Industries : Drug Delivery Technology
  • Countries : United States, Ireland
Cardiometabolic Drug News NOVEMBER 2014

Cardiometabolic Drug News NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Brief - FDA Advisory Committee Recommends Edoxaban Approval In NVAF Industry Brief - Bayer Completes Acquisition Of Merck's Consumer Care Business; Collaboration Comes Into Effect Industry Brief ...

  • Industries : Drug and Medication
  • Countries : United States, Switzerland, Denmark
Respiratory Therapy News OCTOBER 2014

Respiratory Therapy News OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Respiratory Market Stratification Inevitable, Augmented By ERS Revelations Industry Trend Analysis - Teva Follows De-Diversification Trend With Focus On CNS/Respiratory Industry ...

  • Industries : Therapy
  • Countries : United States, Greece, Germany, Japan, Europe, World, Asia
CNS Drug News 13 OCTOBER 2014

CNS Drug News 13 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Progressive MS Pipeline To See Increased Activity Industry Brief - Bayer Comments On NICE Guideline Regarding MS Management Industry Brief - Synthon Files Glatiramer ANDA With ...

  • Industries : Drug and Medication
  • Countries : France, United States, Europe
Drug Delivery Insight 13 OCTOBER 2014

Drug Delivery Insight 13 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Aesica Acquisition Augments Consort's Expansion Strategy Industry Trend Analysis - BD Eyes Accelerated Vertical Expansion Through CareFusion Acquisition Industry Trend Analysis ...

  • Industries : Drug Delivery Technology
  • Countries : United States, Canada, Europe, Portugal, Germany, World, North America
Cancer Drug News 29 SEPTEMBER 2014

Cancer Drug News 29 SEPTEMBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Amgen Vies For Swift Blinatumomab Approval Industry Brief - TG Agrees SPA With FDA For CLL Phase III Trial Industry Brief - Cephalon Acts To End Litigation Against Eagle Industry ...

  • Industries : Drug and Medication
  • Countries : China, Canada, United Kingdom
Cancer Drug News 15 SEPTEMBER 2014

Cancer Drug News 15 SEPTEMBER 2014

  • $ 1 114
  • Industry report
  • September 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Boom In Antibody-Drug Conjugate Market On The Horizon Industry Brief - First Patient Dosed In Phase II Study Of Lucitanib In Advanced BC Industry Trend Analysis - SGX301 Has Potential ...

  • Industries : Drug and Medication
  • Countries : Canada, Japan, United States, Sweden, China, World
Advanced in the Rheumatoid Arthritis Market

Advanced in the Rheumatoid Arthritis Market

  • $ 1 679
  • Industry report
  • January 2014
  • by Espicom Business Intelligence

Rheumatoid arthritis (RA) is a chronic disorder for which there is currently no cure It affects around 23 5 million adults in the world (WHO, 2013) and approximately 294,000 children under the age of ...

  • Industries : Pathology
  • Countries : Japan, United States, Russian Federation, Europe, India, China
Orphan Drugs: Market Environment Products and Companies

Orphan Drugs: Market Environment Products and Companies

  • $ 1 510
  • Industry report
  • December 2012
  • by Espicom Business Intelligence

The combination of government incentives to develop drugs for rare diseases and the promise of commercial opportunity will continue to fuel the industry's interest in orphan drugs; and provide hope to ...

  • Industries : Drug and Medication
  • Countries : United States, Australia, Japan, Sweden
The Pharmaceutical Market: Finland

The Pharmaceutical Market: Finland

  • $ 1 266
  • Industry report
  • June 2012
  • by Espicom Business Intelligence

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...

  • Industries : Pharmaceutical
  • Countries : Finland
The Pharmaceutical Market: Denmark

The Pharmaceutical Market: Denmark

  • $ 1 266
  • Industry report
  • June 2012
  • by Espicom Business Intelligence

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...

  • Industries : Pharmaceutical
  • Countries : Denmark
The Pharmaceutical Market: Austria

The Pharmaceutical Market: Austria

  • $ 1 266
  • Industry report
  • June 2012
  • by Espicom Business Intelligence

Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens ...

  • Industries : Pharmaceutical
  • Countries : Austria
The Pharmaceutical Market: Norway

The Pharmaceutical Market: Norway

  • $ 1 266
  • Industry report
  • June 2012
  • by Espicom Business Intelligence

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...

  • Industries : Pharmaceutical
  • Countries : Norway
The Pharmaceutical Market: Belgium

The Pharmaceutical Market: Belgium

  • $ 1 266
  • Industry report
  • June 2012
  • by Espicom Business Intelligence

Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens ...

  • Industries : Pharmaceutical
  • Countries : Belgium
The Pharmaceutical Market: UK

The Pharmaceutical Market: UK

  • $ 1 266
  • Industry report
  • June 2012
  • by Espicom Business Intelligence

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...

  • Industries : Pharmaceutical
  • Countries : United Kingdom
Gedeon Richter Generics Company Intelligence Report

Gedeon Richter Generics Company Intelligence Report

  • $ 329
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Hungary
ratiopharm Generics Company Intelligence Report

ratiopharm Generics Company Intelligence Report

  • $ 329
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Germany, Canada, Europe, Netherlands, World, North America, United Kingdom
Stada Arzneimittel Generics Company Intelligence Report

Stada Arzneimittel Generics Company Intelligence Report

  • $ 329
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Germany
Krka Generics Company Intelligence Report

Krka Generics Company Intelligence Report

  • $ 329
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Europe, Slovenia, Germany, World, China
Ranbaxy Generics Company Intelligence Report

Ranbaxy Generics Company Intelligence Report

  • $ 329
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : South Africa, Canada, India, World, Africa, United States, Romania, Japan, Mexico, Malaysia, China, North America, Asia, Europe
Sanofi-Aventis Generics Company Intelligence Report

Sanofi-Aventis Generics Company Intelligence Report

  • $ 329
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Czech Republic, United Kingdom, Europe, Brazil, France, Germany, South America, World, Mexico, Slovakia (slovak Republic), Romania, Portugal
Actavis Generics Company Intelligence Report

Actavis Generics Company Intelligence Report

  • $ 329
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : United States, Europe, Iceland, Switzerland, Bulgaria, France, Germany, World, Netherlands, Norway, United Kingdom, Sweden, Spain, Russian Federation, Ireland, Austria, China, Serbia and Montenegro, North America
Egis Generics Company Intelligence Report

Egis Generics Company Intelligence Report

  • $ 329
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Hungary, Europe, Russian Federation, France, Austria, South Korea, World
Bayer: Pipeline - Products ? Performance - Potential

Bayer: Pipeline - Products ? Performance - Potential

  • $ 1 004
  • Company report
  • November 2010
  • by Espicom Business Intelligence

Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...

  • Industries : Over-the-counter Drug
  • Countries : Germany
Multiple Sclerosis Drug Discoveries: what the future holds

Multiple Sclerosis Drug Discoveries: what the future holds

  • $ 2 185
  • Industry report
  • October 2010
  • by Espicom Business Intelligence

EXTENSIVE ANALYSIS OF THE GLOBAL MULTIPLE SCLEROSIS MARKET AND ASSESSMENT OF ALL SIGNIFICANT CURRENT AND FUTURE PRODUCTS The recent approval in the US of Novartis' orally administered Gilenya (fingolimod) ...

  • Industries : Drug Discovery and Development, Pathology
  • Countries : World, Russian Federation
Epigenetics: Current and future applications that are driving novel drug discovery

Epigenetics: Current and future applications that are driving novel drug discovery

  • $ 1 175
  • Industry report
  • August 2010
  • by Espicom Business Intelligence

Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, ...

  • Industries : Drug Discovery and Development, Genomics
  • Countries : United States, Germany, Denmark, World, Canada
Lung Cancer: Global Incidence, Prevalence and Mortality to 2015

Lung Cancer: Global Incidence, Prevalence and Mortality to 2015

  • $ 1 681
  • Industry report
  • July 2010
  • by Espicom Business Intelligence

Lung cancer is expected to account for an estimated 12.5% of all new cancer cases in the leading economies in 2010, giving it the second highest incidence, marginally behind colorectal cancer and just ...

  • Industries : Pathology, Healthcare
  • Countries : Japan, United States, France, Spain, Germany, Italy, United Kingdom, World, Europe
About 7 800 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Industry in the UK

  • Infection Report
  • November 2014
    7 pages
  • Drug And Medica...  

    Antibiotic  

  • United Kingdom  

    Europe  

View report >

Drug Industry In The Uk

November 2014

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.